Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Beevers

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Botanics : Targets and Therapy|March 16, 2026
Pharmacological and clinical properties of curcuminChristopher S Beevers, Shile Huang
Current Drug Targets|October 20, 2010
The targets of curcuminHongyu Zhou, Christopher S Beevers, Shile Huang
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Hitting the golden TORget: curcumin's effects on mTOR signalingChristopher S Beevers, Hongyu Zhou, Shile Huang
International Journal of Cancer|March 22, 2006
Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cellsChristopher S Beevers, Fengjun Li, Lei Liu, et al.
Cancer Research|January 30, 2009
Curcumin disrupts the Mammalian target of rapamycin-raptor complexChristopher S Beevers, Long Chen, Lei Liu, et al.
Carcinogenesis|February 3, 2012
Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cellsXiuzhen Han, Baoshan Xu, Christopher S Beevers, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Botanics : Targets and Therapy|March 16, 2026
Pharmacological and clinical properties of curcuminChristopher S Beevers, Shile Huang
Current Drug Targets|October 20, 2010
The targets of curcuminHongyu Zhou, Christopher S Beevers, Shile Huang
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Hitting the golden TORget: curcumin's effects on mTOR signalingChristopher S Beevers, Hongyu Zhou, Shile Huang
International Journal of Cancer|March 22, 2006
Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cellsChristopher S Beevers, Fengjun Li, Lei Liu, et al.
Cancer Research|January 30, 2009
Curcumin disrupts the Mammalian target of rapamycin-raptor complexChristopher S Beevers, Long Chen, Lei Liu, et al.
Carcinogenesis|February 3, 2012
Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cellsXiuzhen Han, Baoshan Xu, Christopher S Beevers, et al.
Pageof 1